Global Bio-pharma Market Insights and Forecast to 2026

Global Bio-pharma Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Bio-pharma Product Introduction
1.2 Market Segments
1.3 Key Bio-pharma Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bio-pharma Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Recombinant Proteins
1.4.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.4.5 Interferons
1.4.6 Recombinant Human Insulin
1.4.7 Erythropoietin
1.4.8 Vaccines
1.4.9 Growth Hormones
1.4.10 Purified Proteins
1.4.11 Others
1.5 Market by Application
1.5.1 Global Bio-pharma Market Size Growth Rate by Application
1.5.2 Metabolic Disorders
1.5.3 Oncology
1.5.4 Neurological Disorders
1.5.5 Cardiovascular Diseases
1.5.6 Inflammatory and Infectious Diseases
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bio-pharma Market Size, Estimates and Forecasts
2.1.1 Global Bio-pharma Revenue 2015-2026
2.1.2 Global Bio-pharma Sales 2015-2026
2.2 Global Bio-pharma, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bio-pharma Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bio-pharma Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bio-pharma Competitor Landscape by Players
3.1 Bio-pharma Sales by Manufacturers
3.1.1 Bio-pharma Sales by Manufacturers (2015-2020)
3.1.2 Bio-pharma Sales Market Share by Manufacturers (2015-2020)
3.2 Bio-pharma Revenue by Manufacturers
3.2.1 Bio-pharma Revenue by Manufacturers (2015-2020)
3.2.2 Bio-pharma Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bio-pharma Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bio-pharma Revenue in 2019
3.2.5 Global Bio-pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bio-pharma Price by Manufacturers
3.4 Bio-pharma Manufacturing Base Distribution, Product Types
3.4.1 Bio-pharma Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bio-pharma Product Type
3.4.3 Date of International Manufacturers Enter into Bio-pharma Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bio-pharma Market Size by Type (2015-2020)
4.1.1 Global Bio-pharma Sales by Type (2015-2020)
4.1.2 Global Bio-pharma Revenue by Type (2015-2020)
4.1.3 Bio-pharma Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bio-pharma Market Size Forecast by Type (2021-2026)
4.2.1 Global Bio-pharma Sales Forecast by Type (2021-2026)
4.2.2 Global Bio-pharma Revenue Forecast by Type (2021-2026)
4.2.3 Bio-pharma Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bio-pharma Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bio-pharma Market Size by Application (2015-2020)
5.1.1 Global Bio-pharma Sales by Application (2015-2020)
5.1.2 Global Bio-pharma Revenue by Application (2015-2020)
5.1.3 Bio-pharma Price by Application (2015-2020)
5.2 Bio-pharma Market Size Forecast by Application (2021-2026)
5.2.1 Global Bio-pharma Sales Forecast by Application (2021-2026)
5.2.2 Global Bio-pharma Revenue Forecast by Application (2021-2026)
5.2.3 Global Bio-pharma Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bio-pharma by Country
6.1.1 North America Bio-pharma Sales by Country
6.1.2 North America Bio-pharma Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bio-pharma Market Facts & Figures by Type
6.3 North America Bio-pharma Market Facts & Figures by Application
7 Europe
7.1 Europe Bio-pharma by Country
7.1.1 Europe Bio-pharma Sales by Country
7.1.2 Europe Bio-pharma Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bio-pharma Market Facts & Figures by Type
7.3 Europe Bio-pharma Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bio-pharma by Region
8.1.1 Asia Pacific Bio-pharma Sales by Region
8.1.2 Asia Pacific Bio-pharma Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bio-pharma Market Facts & Figures by Type
8.3 Asia Pacific Bio-pharma Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bio-pharma by Country
9.1.1 Latin America Bio-pharma Sales by Country
9.1.2 Latin America Bio-pharma Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bio-pharma Market Facts & Figures by Type
9.3 Central & South America Bio-pharma Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bio-pharma by Country
10.1.1 Middle East and Africa Bio-pharma Sales by Country
10.1.2 Middle East and Africa Bio-pharma Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bio-pharma Market Facts & Figures by Type
10.3 Middle East and Africa Bio-pharma Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Bio-pharma Products Offered
11.1.5 Pfizer Related Developments
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Corporation Information
11.2.2 F. Hoffmann-La Roche AG Description and Business Overview
11.2.3 F. Hoffmann-La Roche AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 F. Hoffmann-La Roche AG Bio-pharma Products Offered
11.2.5 F. Hoffmann-La Roche AG Related Developments
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Corporation Information
11.3.2 Johnson & Johnson Services Description and Business Overview
11.3.3 Johnson & Johnson Services Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Services Bio-pharma Products Offered
11.3.5 Johnson & Johnson Services Related Developments
11.4 Sanofi, Amgen
11.4.1 Sanofi, Amgen Corporation Information
11.4.2 Sanofi, Amgen Description and Business Overview
11.4.3 Sanofi, Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi, Amgen Bio-pharma Products Offered
11.4.5 Sanofi, Amgen Related Developments
11.5 AbbVie
11.5.1 AbbVie Corporation Information
11.5.2 AbbVie Description and Business Overview
11.5.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AbbVie Bio-pharma Products Offered
11.5.5 AbbVie Related Developments
11.6 Merck & Co., Inc
11.6.1 Merck & Co., Inc Corporation Information
11.6.2 Merck & Co., Inc Description and Business Overview
11.6.3 Merck & Co., Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck & Co., Inc Bio-pharma Products Offered
11.6.5 Merck & Co., Inc Related Developments
11.7 Biogen Idec
11.7.1 Biogen Idec Corporation Information
11.7.2 Biogen Idec Description and Business Overview
11.7.3 Biogen Idec Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biogen Idec Bio-pharma Products Offered
11.7.5 Biogen Idec Related Developments
11.8 Bayer AG
11.8.1 Bayer AG Corporation Information
11.8.2 Bayer AG Description and Business Overview
11.8.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bayer AG Bio-pharma Products Offered
11.8.5 Bayer AG Related Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Corporation Information
11.9.2 Eli Lilly and Company Description and Business Overview
11.9.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eli Lilly and Company Bio-pharma Products Offered
11.9.5 Eli Lilly and Company Related Developments
11.10 Novartis AG GlaxoSmithKline Plc
11.10.1 Novartis AG GlaxoSmithKline Plc Corporation Information
11.10.2 Novartis AG GlaxoSmithKline Plc Description and Business Overview
11.10.3 Novartis AG GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Products Offered
11.10.5 Novartis AG GlaxoSmithKline Plc Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Bio-pharma Products Offered
11.1.5 Pfizer Related Developments
11.12 AstraZeneca PLC
11.12.1 AstraZeneca PLC Corporation Information
11.12.2 AstraZeneca PLC Description and Business Overview
11.12.3 AstraZeneca PLC Sales, Revenue and Gross Margin (2015-2020)
11.12.4 AstraZeneca PLC Products Offered
11.12.5 AstraZeneca PLC Related Developments
11.13 Abbott Laboratories
11.13.1 Abbott Laboratories Corporation Information
11.13.2 Abbott Laboratories Description and Business Overview
11.13.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Abbott Laboratories Products Offered
11.13.5 Abbott Laboratories Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bio-pharma Market Estimates and Projections by Region
12.1.1 Global Bio-pharma Sales Forecast by Regions 2021-2026
12.1.2 Global Bio-pharma Revenue Forecast by Regions 2021-2026
12.2 North America Bio-pharma Market Size Forecast (2021-2026)
12.2.1 North America: Bio-pharma Sales Forecast (2021-2026)
12.2.2 North America: Bio-pharma Revenue Forecast (2021-2026)
12.2.3 North America: Bio-pharma Market Size Forecast by Country (2021-2026)
12.3 Europe Bio-pharma Market Size Forecast (2021-2026)
12.3.1 Europe: Bio-pharma Sales Forecast (2021-2026)
12.3.2 Europe: Bio-pharma Revenue Forecast (2021-2026)
12.3.3 Europe: Bio-pharma Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bio-pharma Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bio-pharma Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bio-pharma Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bio-pharma Market Size Forecast by Region (2021-2026)
12.5 Latin America Bio-pharma Market Size Forecast (2021-2026)
12.5.1 Latin America: Bio-pharma Sales Forecast (2021-2026)
12.5.2 Latin America: Bio-pharma Revenue Forecast (2021-2026)
12.5.3 Latin America: Bio-pharma Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bio-pharma Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bio-pharma Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bio-pharma Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bio-pharma Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Bio-pharma Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bio-pharma Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Bio-pharma Market Segments
Table 2. Ranking of Global Top Bio-pharma Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bio-pharma Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Recombinant Proteins
Table 6. Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 7. Major Manufacturers of Interferons
Table 8. Major Manufacturers of Recombinant Human Insulin
Table 9. Major Manufacturers of Erythropoietin
Table 10. Major Manufacturers of Vaccines
Table 11. Major Manufacturers of Growth Hormones
Table 12. Major Manufacturers of Purified Proteins
Table 13. Major Manufacturers of Others
Table 14. Global Bio-pharma Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 15. Global Bio-pharma Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 16. Global Bio-pharma Sales by Regions 2015-2020 (K Pcs)
Table 17. Global Bio-pharma Sales Market Share by Regions (2015-2020)
Table 18. Global Bio-pharma Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Bio-pharma Sales by Manufacturers (2015-2020) (K Pcs)
Table 20. Global Bio-pharma Sales Share by Manufacturers (2015-2020)
Table 21. Global Bio-pharma Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Bio-pharma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio-pharma as of 2019)
Table 23. Bio-pharma Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Bio-pharma Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Bio-pharma Price (2015-2020) (USD/Pcs)
Table 26. Bio-pharma Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Bio-pharma Product Type
Table 28. Date of International Manufacturers Enter into Bio-pharma Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 31. Global Bio-pharma Sales Share by Type (2015-2020)
Table 32. Global Bio-pharma Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Bio-pharma Revenue Share by Type (2015-2020)
Table 34. Bio-pharma Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 35. Global Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 36. Global Bio-pharma Sales Share by Application (2015-2020)
Table 37. North America Bio-pharma Sales by Country (2015-2020) (K Pcs)
Table 38. North America Bio-pharma Sales Market Share by Country (2015-2020)
Table 39. North America Bio-pharma Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Bio-pharma Revenue Market Share by Country (2015-2020)
Table 41. North America Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 42. North America Bio-pharma Sales Market Share by Type (2015-2020)
Table 43. North America Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 44. North America Bio-pharma Sales Market Share by Application (2015-2020)
Table 45. Europe Bio-pharma Sales by Country (2015-2020) (K Pcs)
Table 46. Europe Bio-pharma Sales Market Share by Country (2015-2020)
Table 47. Europe Bio-pharma Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Bio-pharma Revenue Market Share by Country (2015-2020)
Table 49. Europe Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 50. Europe Bio-pharma Sales Market Share by Type (2015-2020)
Table 51. Europe Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 52. Europe Bio-pharma Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Bio-pharma Sales by Region (2015-2020) (K Pcs)
Table 54. Asia Pacific Bio-pharma Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Bio-pharma Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Bio-pharma Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 58. Asia Pacific Bio-pharma Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 60. Asia Pacific Bio-pharma Sales Market Share by Application (2015-2020)
Table 61. Latin America Bio-pharma Sales by Country (2015-2020) (K Pcs)
Table 62. Latin America Bio-pharma Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Bio-pharma Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Bio-pharma Revenue Market Share by Country (2015-2020)
Table 65. Latin America Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 66. Latin America Bio-pharma Sales Market Share by Type (2015-2020)
Table 67. Latin America Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 68. Latin America Bio-pharma Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Bio-pharma Sales by Country (2015-2020) (K Pcs)
Table 70. Middle East and Africa Bio-pharma Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Bio-pharma Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Bio-pharma Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 74. Middle East and Africa Bio-pharma Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 76. Middle East and Africa Bio-pharma Sales Market Share by Application (2015-2020)
Table 77. Pfizer Corporation Information
Table 78. Pfizer Description and Major Businesses
Table 79. Pfizer Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Pfizer Product
Table 81. Pfizer Recent Development
Table 82. F. Hoffmann-La Roche AG Corporation Information
Table 83. F. Hoffmann-La Roche AG Description and Major Businesses
Table 84. F. Hoffmann-La Roche AG Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. F. Hoffmann-La Roche AG Product
Table 86. F. Hoffmann-La Roche AG Recent Development
Table 87. Johnson & Johnson Services Corporation Information
Table 88. Johnson & Johnson Services Description and Major Businesses
Table 89. Johnson & Johnson Services Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Johnson & Johnson Services Product
Table 91. Johnson & Johnson Services Recent Development
Table 92. Sanofi, Amgen Corporation Information
Table 93. Sanofi, Amgen Description and Major Businesses
Table 94. Sanofi, Amgen Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Sanofi, Amgen Product
Table 96. Sanofi, Amgen Recent Development
Table 97. AbbVie Corporation Information
Table 98. AbbVie Description and Major Businesses
Table 99. AbbVie Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. AbbVie Product
Table 101. AbbVie Recent Development
Table 102. Merck & Co., Inc Corporation Information
Table 103. Merck & Co., Inc Description and Major Businesses
Table 104. Merck & Co., Inc Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Merck & Co., Inc Product
Table 106. Merck & Co., Inc Recent Development
Table 107. Biogen Idec Corporation Information
Table 108. Biogen Idec Description and Major Businesses
Table 109. Biogen Idec Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Biogen Idec Product
Table 111. Biogen Idec Recent Development
Table 112. Bayer AG Corporation Information
Table 113. Bayer AG Description and Major Businesses
Table 114. Bayer AG Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Bayer AG Product
Table 116. Bayer AG Recent Development
Table 117. Eli Lilly and Company Corporation Information
Table 118. Eli Lilly and Company Description and Major Businesses
Table 119. Eli Lilly and Company Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Eli Lilly and Company Product
Table 121. Eli Lilly and Company Recent Development
Table 122. Novartis AG GlaxoSmithKline Plc Corporation Information
Table 123. Novartis AG GlaxoSmithKline Plc Description and Major Businesses
Table 124. Novartis AG GlaxoSmithKline Plc Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Novartis AG GlaxoSmithKline Plc Product
Table 126. Novartis AG GlaxoSmithKline Plc Recent Development
Table 127. Bristol-Myers Squibb Company Corporation Information
Table 128. Bristol-Myers Squibb Company Description and Major Businesses
Table 129. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Bristol-Myers Squibb Company Product
Table 131. Bristol-Myers Squibb Company Recent Development
Table 132. AstraZeneca PLC Corporation Information
Table 133. AstraZeneca PLC Description and Major Businesses
Table 134. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. AstraZeneca PLC Product
Table 136. AstraZeneca PLC Recent Development
Table 137. Abbott Laboratories Corporation Information
Table 138. Abbott Laboratories Description and Major Businesses
Table 139. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Abbott Laboratories Product
Table 141. Abbott Laboratories Recent Development
Table 142. Global Bio-pharma Sales Forecast by Regions (2021-2026) (K Pcs)
Table 143. Global Bio-pharma Sales Market Share Forecast by Regions (2021-2026)
Table 144. Global Bio-pharma Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 145. Global Bio-pharma Revenue Market Share Forecast by Regions (2021-2026)
Table 146. North America: Bio-pharma Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. North America: Bio-pharma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Europe: Bio-pharma Sales Forecast by Country (2021-2026) (K Pcs)
Table 149. Europe: Bio-pharma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Asia Pacific: Bio-pharma Sales Forecast by Region (2021-2026) (K Pcs)
Table 151. Asia Pacific: Bio-pharma Revenue Forecast by Region (2021-2026) (US$ Million)
Table 152. Latin America: Bio-pharma Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. Latin America: Bio-pharma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Middle East and Africa: Bio-pharma Sales Forecast by Country (2021-2026) (K Pcs)
Table 155. Middle East and Africa: Bio-pharma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 157. Key Challenges
Table 158. Market Risks
Table 159. Main Points Interviewed from Key Bio-pharma Players
Table 160. Bio-pharma Customers List
Table 161. Bio-pharma Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-pharma Product Picture
Figure 2. Global Bio-pharma Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Recombinant Proteins Product Picture
Figure 5. Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure 6. Interferons Product Picture
Figure 7. Recombinant Human Insulin Product Picture
Figure 8. Erythropoietin Product Picture
Figure 9. Vaccines Product Picture
Figure 10. Growth Hormones Product Picture
Figure 11. Purified Proteins Product Picture
Figure 12. Others Product Picture
Figure 13. Global Bio-pharma Sales Market Share by Application in 2020 & 2026
Figure 14. Metabolic Disorders
Figure 15. Oncology
Figure 16. Neurological Disorders
Figure 17. Cardiovascular Diseases
Figure 18. Inflammatory and Infectious Diseases
Figure 19. Others
Figure 20. Bio-pharma Report Years Considered
Figure 21. Global Bio-pharma Market Size 2015-2026 (US$ Million)
Figure 22. Global Bio-pharma Sales 2015-2026 (K Pcs)
Figure 23. Global Bio-pharma Market Size Market Share by Region: 2020 Versus 2026
Figure 24. Global Bio-pharma Sales Market Share by Region (2015-2020)
Figure 25. Global Bio-pharma Sales Market Share by Region in 2019
Figure 26. Global Bio-pharma Revenue Market Share by Region (2015-2020)
Figure 27. Global Bio-pharma Revenue Market Share by Region in 2019
Figure 28. Global Bio-pharma Sales Share by Manufacturer in 2019
Figure 29. The Top 10 and 5 Players Market Share by Bio-pharma Revenue in 2019
Figure 30. Bio-pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Bio-pharma Sales Market Share by Type (2015-2020)
Figure 32. Global Bio-pharma Sales Market Share by Type in 2019
Figure 33. Global Bio-pharma Revenue Market Share by Type (2015-2020)
Figure 34. Global Bio-pharma Revenue Market Share by Type in 2019
Figure 35. Global Bio-pharma Market Share by Price Range (2015-2020)
Figure 36. Global Bio-pharma Sales Market Share by Application (2015-2020)
Figure 37. Global Bio-pharma Sales Market Share by Application in 2019
Figure 38. Global Bio-pharma Revenue Market Share by Application (2015-2020)
Figure 39. Global Bio-pharma Revenue Market Share by Application in 2019
Figure 40. North America Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. North America Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America Bio-pharma Sales Market Share by Country in 2019
Figure 43. North America Bio-pharma Revenue Market Share by Country in 2019
Figure 44. U.S. Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. U.S. Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Canada Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. North America Bio-pharma Market Share by Type in 2019
Figure 49. North America Bio-pharma Market Share by Application in 2019
Figure 50. Europe Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Bio-pharma Sales Market Share by Country in 2019
Figure 53. Europe Bio-pharma Revenue Market Share by Country in 2019
Figure 54. Germany Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Europe Bio-pharma Market Share by Type in 2019
Figure 65. Europe Bio-pharma Market Share by Application in 2019
Figure 66. Asia Pacific Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 67. Asia Pacific Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 68. Asia Pacific Bio-pharma Sales Market Share by Region in 2019
Figure 69. Asia Pacific Bio-pharma Revenue Market Share by Region in 2019
Figure 70. China Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. China Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Japan Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Japan Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. South Korea Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. South Korea Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. India Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. India Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Australia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Australia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Taiwan Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Taiwan Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Indonesia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Indonesia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Thailand Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Thailand Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Malaysia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Malaysia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Philippines Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Philippines Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Vietnam Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Vietnam Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Asia Pacific Bio-pharma Market Share by Type in 2019
Figure 93. Asia Pacific Bio-pharma Market Share by Application in 2019
Figure 94. Latin America Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 95. Latin America Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Latin America Bio-pharma Sales Market Share by Country in 2019
Figure 97. Latin America Bio-pharma Revenue Market Share by Country in 2019
Figure 98. Mexico Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Mexico Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Brazil Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Brazil Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Argentina Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Argentina Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Latin America Bio-pharma Market Share by Type in 2019
Figure 105. Latin America Bio-pharma Market Share by Application in 2019
Figure 106. Middle East and Africa Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 107. Middle East and Africa Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 108. Middle East and Africa Bio-pharma Sales Market Share by Country in 2019
Figure 109. Middle East and Africa Bio-pharma Revenue Market Share by Country in 2019
Figure 110. Turkey Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 111. Turkey Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Saudi Arabia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 113. Saudi Arabia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 114. U.A.E Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 115. U.A.E Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 116. Middle East and Africa Bio-pharma Market Share by Type in 2019
Figure 117. Middle East and Africa Bio-pharma Market Share by Application in 2019
Figure 118. North America Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. North America Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Europe Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Asia Pacific Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 125. Latin America Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 127. Middle East and Africa Bio-pharma Revenue Growth Rate Forecast

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......

Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Bio-Pharma market: According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......

Global Bio-pharma Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 91

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, Amgen - AbbVie - Merck & Co., Inc - Biogen Idec - Bayer AG - E......

Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028

Published: 24-Nov-2023        Price: US 4950 Onwards        Pages: 273

“Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.” The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......

Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028

Published: 20-Nov-2023        Price: US 3280 Onwards        Pages: 139

A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......

Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028

Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 160

A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......

2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel

Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 85

This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biopharmaceutic......

Global Bio-pharma Market Insights, Forecast to 2029

Published: 10-Aug-2023        Price: US 4900 Onwards        Pages: 108

The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......

Biopharmaceuticals Markets in China

Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 233

China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs